ACHV
Price
$2.96
Change
-$0.01 (-0.34%)
Updated
Sep 26, 12:55 PM (EDT)
Capitalization
151.78M
41 days until earnings call
NAUT
Price
$0.82
Change
-$0.00 (-0.00%)
Updated
Sep 26, 01:19 PM (EDT)
Capitalization
103.84M
39 days until earnings call
Interact to see
Advertisement

ACHV vs NAUT

Header iconACHV vs NAUT Comparison
Open Charts ACHV vs NAUTBanner chart's image
Achieve Life Sciences
Price$2.96
Change-$0.01 (-0.34%)
Volume$100
Capitalization151.78M
Nautilus Biotechnolgy
Price$0.82
Change-$0.00 (-0.00%)
Volume$438
Capitalization103.84M
ACHV vs NAUT Comparison Chart in %
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHV vs. NAUT commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Buy and NAUT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ACHV: $2.97 vs. NAUT: $0.82)
Brand notoriety: ACHV and NAUT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 28% vs. NAUT: 410%
Market capitalization -- ACHV: $151.78M vs. NAUT: $103.84M
ACHV [@Biotechnology] is valued at $151.78M. NAUT’s [@Biotechnology] market capitalization is $103.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileNAUT’s FA Score has 1 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • NAUT’s FA Score: 1 green, 4 red.
According to our system of comparison, NAUT is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 4 TA indicator(s) are bullish while NAUT’s TA Score has 6 bullish TA indicator(s).

  • ACHV’s TA Score: 4 bullish, 6 bearish.
  • NAUT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NAUT is a better buy in the short-term than ACHV.

Price Growth

ACHV (@Biotechnology) experienced а +3.48% price change this week, while NAUT (@Biotechnology) price change was +12.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +49.54%.

Reported Earning Dates

ACHV is expected to report earnings on Nov 06, 2025.

NAUT is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHV($152M) has a higher market cap than NAUT($104M). ACHV YTD gains are higher at: -15.625 vs. NAUT (-51.065). ACHV has higher annual earnings (EBITDA): -49.25M vs. NAUT (-68.6M). NAUT has more cash in the bank: 148M vs. ACHV (55.4M). ACHV has less debt than NAUT: ACHV (9.96M) vs NAUT (28.2M). ACHV (0) and NAUT (0) have equivalent revenues.
ACHVNAUTACHV / NAUT
Capitalization152M104M146%
EBITDA-49.25M-68.6M72%
Gain YTD-15.625-51.06531%
P/E RatioN/AN/A-
Revenue00-
Total Cash55.4M148M37%
Total Debt9.96M28.2M35%
FUNDAMENTALS RATINGS
ACHV vs NAUT: Fundamental Ratings
ACHV
NAUT
OUTLOOK RATING
1..100
5813
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
11
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
6365
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAUT's Valuation (11) in the null industry is somewhat better than the same rating for ACHV (51) in the Biotechnology industry. This means that NAUT’s stock grew somewhat faster than ACHV’s over the last 12 months.

NAUT's Profit vs Risk Rating (100) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that NAUT’s stock grew similarly to ACHV’s over the last 12 months.

NAUT's SMR Rating (97) in the null industry is in the same range as ACHV (99) in the Biotechnology industry. This means that NAUT’s stock grew similarly to ACHV’s over the last 12 months.

ACHV's Price Growth Rating (63) in the Biotechnology industry is in the same range as NAUT (65) in the null industry. This means that ACHV’s stock grew similarly to NAUT’s over the last 12 months.

ACHV's P/E Growth Rating (100) in the Biotechnology industry is in the same range as NAUT (100) in the null industry. This means that ACHV’s stock grew similarly to NAUT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVNAUT
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPAUF0.10N/A
+1.26%
Spanish Mountain Gold Ltd.
REPYF17.92N/A
N/A
Repsol S.A.
UNLRF0.09N/A
N/A
PT Unilever Indonesia Tbk
SWDCF3.58N/A
N/A
SWEDENCARE AB
CBUTD0.03N/A
N/A
CLEAR BLUE TECHNOLOGIES INTL INC.

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ALT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-3.57%
ALT - ACHV
52%
Loosely correlated
N/A
ATNM - ACHV
39%
Loosely correlated
-1.85%
PLRX - ACHV
36%
Loosely correlated
-1.37%
NAUT - ACHV
34%
Loosely correlated
+14.16%
HOWL - ACHV
33%
Loosely correlated
-2.65%
More

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with AXON. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
+14.16%
AXON - NAUT
42%
Loosely correlated
+2.02%
FHTX - NAUT
39%
Loosely correlated
-4.48%
ARRY - NAUT
38%
Loosely correlated
+2.51%
RXRX - NAUT
37%
Loosely correlated
-5.12%
NRIX - NAUT
37%
Loosely correlated
-4.25%
More